Neuraxpharm Reinforces European CNS Leadership Position With Pharmax Acquisition
Neuraxpharm has acquired CNS specialty pharmaceutical company Farmax from SVUS Pharma, in a move that strengthens the firm’s European CNS leadership position by entering the Czech Republic, Slovakia and Hungary.
You may also be interested in...
After recently rebranding the company, Neuraxpharm has put expansion plans in place that have allowed it to reach over 70% of the European central nervous system market, resulting in projections of organic sales growth of 10% and gross sales of €400m for this year.
Neuraxpharm has appointed Craig Bowen as general manager of its UK affiliate at the same time as the European central nervous system specialist has launched its first products in the UK market.
Neuraxpharm has kicked off its operations in Poland with the appointment of Wojciech Góra as general manager of its new Neuraxpharm Polska business.